TY - JOUR
T1 - Prospective Epidemiological Research Studies in Iran (the PERSIAN Cohort Study)
T2 - Rationale, Objectives, and Design
AU - Poustchi, Hossein
AU - Eghtesad, Sareh
AU - Kamangar, Farin
AU - Etemadi, Arash
AU - Keshtkar, Abbas Ali
AU - Hekmatdoost, Azita
AU - Mohammadi, Zahra
AU - Mahmoudi, Zahra
AU - Shayanrad, Amaneh
AU - Roozafzai, Farzin
AU - Sheikh, Mahdi
AU - Jalaeikhoo, Alireza
AU - Somi, Mohammad Hossein
AU - Mansour-Ghanaei, Fariborz
AU - Najafi, Farid
AU - Bahramali, Ehsan
AU - Mehrparvar, Amirhoushang
AU - Ansari-Moghaddam, Alireza
AU - Enayati, Ahmad Ali
AU - Esmaeili Nadimi, Ali
AU - Rezaianzadeh, Abbas
AU - Saki, Nader
AU - Alipour, Fatemeh
AU - Kelishadi, Roya
AU - Rahimi-Movaghar, Afarin
AU - Aminisani, Nayyereh
AU - Boffetta, Paolo
AU - Malekzadeh, Reza
N1 - Publisher Copyright:
© The Author(s) 2018. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved.
PY - 2018/4/1
Y1 - 2018/4/1
N2 - Noncommunicable diseases (NCDs) account for 76% of deaths in Iran, and this number is on the rise, in parallel with global rates. Many risk factors associated with NCDs are preventable; however, it is first necessary to conduct observational studies to identify relevant risk factors and the most appropriate approach to controlling them. Iran is a multiethnic country; therefore, in 2014 the Ministry of Health and Medical Education launched a nationwide cohort study - Prospective Epidemiological Research Studies in Iran (PERSIAN) - in order to identify the most prevalent NCDs among Iran's ethnic groups and to investigate effective methods of prevention. The PERSIAN study consists of 4 population-based cohorts; the adult component (the PERSIAN Cohort Study), described in this article, is a prospective cohort study including 180,000 persons aged 35-70 years from 18 distinct areas of Iran. Upon joining the cohort, participants respond to interviewer-administered questionnaires. Blood, urine, hair, and nail samples are collected and stored. To ensure consistency, centrally purchased equipment is sent to all sites, and the same team trains all personnel. Routine visits and quality assurance/control measures are taken to ensure protocol adherence. Participants are followed for 15 years postenrollment. The PERSIAN study is currently in the enrollment phase; cohort profiles will soon emerge.
AB - Noncommunicable diseases (NCDs) account for 76% of deaths in Iran, and this number is on the rise, in parallel with global rates. Many risk factors associated with NCDs are preventable; however, it is first necessary to conduct observational studies to identify relevant risk factors and the most appropriate approach to controlling them. Iran is a multiethnic country; therefore, in 2014 the Ministry of Health and Medical Education launched a nationwide cohort study - Prospective Epidemiological Research Studies in Iran (PERSIAN) - in order to identify the most prevalent NCDs among Iran's ethnic groups and to investigate effective methods of prevention. The PERSIAN study consists of 4 population-based cohorts; the adult component (the PERSIAN Cohort Study), described in this article, is a prospective cohort study including 180,000 persons aged 35-70 years from 18 distinct areas of Iran. Upon joining the cohort, participants respond to interviewer-administered questionnaires. Blood, urine, hair, and nail samples are collected and stored. To ensure consistency, centrally purchased equipment is sent to all sites, and the same team trains all personnel. Routine visits and quality assurance/control measures are taken to ensure protocol adherence. Participants are followed for 15 years postenrollment. The PERSIAN study is currently in the enrollment phase; cohort profiles will soon emerge.
KW - cohort studies
KW - Iran
KW - noncommunicable diseases
KW - Prospective Epidemiological Research Studies in Iran (PERSIAN)
UR - https://www.scopus.com/pages/publications/85042090127
U2 - 10.1093/aje/kwx314
DO - 10.1093/aje/kwx314
M3 - Article
C2 - 29145581
AN - SCOPUS:85042090127
SN - 0002-9262
VL - 187
SP - 647
EP - 655
JO - American Journal of Epidemiology
JF - American Journal of Epidemiology
IS - 4
ER -